METHOD FOR PREVENTING AND TREATING BENIGN BREAST DYSPLASIA IN PATIENTS WITH EARLY MISCARRIAGE

摘要

The method for preventing and treating benign breast dysplasia in the patients with early miscarriage comprises the background therapy with the use of Serrata as complex enzyme drug and Tazalok as phytomammoprotector at the average therapeutic doses.